-
My Account
My Account
BSE Live
Jul 01, 16:01Prev. Close
4399.90
Open Price
4370.05
Bid Price (Qty.)
4379.30 (10)
Offer Price (Qty.)
4384.35 (3)
NSE Live
Jul 01, 15:58Prev. Close
4393.80
Open Price
4385.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4385.90 (29)
| Cash Flow of Dr Reddys Laboratories (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 3,056.20 | 2,775.80 | 1,700.70 | 697.00 | |
| Net CashFlow From Operating Activities | 0.00 | 3,514.20 | 1,839.20 | 2,762.10 | 1,538.60 | |
| Net Cash Used In Investing Activities | 0.00 | -1,458.00 | -1,689.20 | -550.90 | -1,179.90 | |
| Net Cash Used From Financing Activities | 0.00 | -794.30 | -224.10 | -2,223.10 | -304.40 | |
| Foreign Exchange Gains / Losses | 0.00 | 4.40 | 0.00 | 4.40 | -0.30 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 1,266.30 | -74.10 | -7.50 | 54.00 | |
| Cash And Cash Equivalents Begin of Year | 0.00 | 39.10 | 113.20 | 120.70 | 66.70 | |
| Cash And Cash Equivalents End Of Year | 0.00 | 1,305.40 | 39.10 | 113.20 | 120.70 |
19.05.2022
Dr Reddys Labs Consolidated March 2022 Net Sales at Rs 5,474.90 crore, up 14.82% Y-o-Y
19.05.2022
Dr Reddys Labs Standalone March 2022 Net Sales at Rs 3,668.70 crore, up 9.49% Y-o-Y
19.05.2022
Dr Reddy's Q4 consolidated net profit slumps 76% despite 15% rise in revenue
01.02.2022
Dr Reddys Labs Consolidated December 2021 Net Sales at Rs 5,338.30 crore, up 8.02% Y-o-Y
28.01.2022
Dr Reddy’s Q3 Preview | Revenue expected to increase 10-15%, PAT likely to grow 22-25%
06.10.2021
Dr. Reddy’s Laboratories Q2 PAT may dip 11.5% YoY to Rs 752.2 cr: Prabhudas Lilladher
13.07.2021
Dr. Reddy’s Laboratories Q1 PAT seen up 10.2% YoY to Rs 655.4 cr: KRChoksey
12.07.2021
Dr Reddy’s Q1 PAT seen up 5.4% YoY to Rs 626.7 cr: ICICI Direct
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
